Warfarin News and Research

RSS

Warfarin is a drug that prevents blood from clotting. It belongs to the family of drugs called anticoagulants (blood thinners).

Study suggests that patients with pulmonary arterial hypertension may benefit from Thelin therapy

Encysive Pharmaceuticals today announced the presentation of data from a clinical study of Thelin(TM) (sitaxsentan) in pulmonary arterial hypertension (PAH), at the European Society of Cardiology Annual Congress in Munich.

31 Aug 2004

As medicine targets personal DNA profiles, researchers examine ethics and patient experiences

Researchers at the University of York are beginning a major study into the ethical and personal issues raised by a potential revolution in healthcare, which could incorporate individualised medical care – pharmacogenetics - into clinical practice.

5 Aug 2004

Adverse drug reactions cost the NHS £466m a year

Adverse drug reactions account for 1 in 16 hospital admissions and cost the NHS £466m a year, according to a study in this week's BMJ.

2 Jul 2004

Better stroke care could save thousands of lives every year

An eight-month study at 21 Canadian hospitals, led by a Canadian Stroke Network and Heart and Stroke Foundation researcher, found that the majority of patients did not receive care on an acute stroke unit.

25 Jun 2004

Researchers have recreated the ability of mammalian cells to self-organize

For the first time, UCLA researchers have recreated the ability of mammalian cells to self-organize, forming evenly spaced patterns in a test tube. Published in the June 22, 2004 issue of the Proceedings of the National Academy of Sciences, the findings may help improve methods for regenerating tissue, controlling birth defects and developing new treatments for specific diseases.

14 Jun 2004

Anti-clotting treatment underused at many hospitals

Academic hospitals are more likely than community or Veteran’s Administration (VA) hospitals to follow national guidelines for treating patients at risk for blood clots with aspirin or warfarin.

19 May 2004